Diabetes stands for a kind of disease, especially diabetes mellitus, characterized by super high levels of glucose (sugar) in the blood. The product categories for this condition’s management fall within glucose monitoring devices (e.g. lancets, blood glucose meters) and insulin administration devices (e.g. insulin pumps, pens and syringes).
Globally, the Diabetes Care Market trends toward approaching far over EUR 19 billion by end-2018. The market will primarily be jet-propelled by the universal upsurge in the diabetes-stricken population, and the fast adoption tempos of less or non-invasive breakthroughs, including, among others, the EyeSense's blood glucose monitoring (BGM) devices, NBM-200G, 8 MediSensors' optical glucose monitoring technologies, Easy Check’s breath-based glucose testers. The dominating vendors in this marketplace include Roche, LifeScan, Sanofi, Novo Nordisk, Bayer Diabetes, and Lilly.
The research reports within the confines of this Catalogue analyze the Diabetes Care Market’s performance in a worldwide scenario, as well as across different geographies. The researches extensively review major market trends, driving forces and restraints for giving a clearer idea of the market structure. Additionally, the reports give unbiased insights into the competitive environment, major producers of anti-diabetic medications and diabetes devices, key products marketed and those currently in development. The global Diabetes Care Market forecasts are also available in the research reports.
Publications found:
434
Sort by:
Insulin Delivery Devices Market Size, Share and Growth Outlook 2026: By Product Type (Insulin Pens, Insulin Pumps, Insulin Syringes, Insulin Jet Injectors, Insulin Pen Needles), By Disease Type, By Distribution Channel, By End User, Companies to 2034
US$ 3,482.00
The global Insulin Delivery Devices Market size is forecast to increase from $40.1 Billion in 2026 to $75.33 Billion in 2034 at a CAGR of 8.2% between 2026 and 2034. The Insulin Delivery Devices marke...
July 2026
190 pages
Insulin Patch Pump Market - 2026-2035
US$ 3,400.00
Insulin Patch Pump Market reached US$ 1.72 Billion in 2025 and is expected to reach US$ 5.53 billion by 2035, growing with a CAGR of 12.30% during the forecast period 2026-2035. The Insulin Patch Pump...
June 2026
44 pages
Non-Invasive Glucose Monitoring Market Forecasts to 2034 – Global Analysis By Technology (Optical Spectroscopy, Transdermal Technology, Electromagnetic Sensing, Fluorescence-based Monitoring, Bioimpedance Spectroscopy, Thermal Emission Technology, Saliva-based Glucose Monitoring, Tear-based Glucose Monitoring, and Breath-based Glucose Monitoring), Device Type, Product Type, Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Non-Invasive Glucose Monitoring Market is accounted for $1.9 billion in 2026 and is expected to reach $12.4 billion by 2034, growing at a CAGR of 26.3% during...
June 2026
200 pages
Insulin Pump Market Size, Share & Trends Analysis Report By Product (Tubed Pump, Tubeless Insulin Pump), By System Architecture (Open-loop, Closed-Loop), By End Use (Hospitals & Care Providers, Homecare), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global insulin pump market size was valued at USD 7.2 billion in 2025 and is projected to grow from USD 7.8 billion in 2026 to USD 13.1 billion by 2033, growing at a CAGR of 7.8% from 2026 to 2033...
June 2026
160 pages
Pen Needles Market Size, Share & Trends Analysis Report By Product (Standard Pen Needles, Safety Pen Needles), By Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), By Therapy (Insulin, Glucagon-like-peptide-1), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global pen needles market is expected to reach a value of USD 4.8 billion by 2025, according to a new report by ... prevalence of diabetes is the primary reason for the significant growth of pen needles market. According to the International Diabetes Federation (IDF), nearly 415 million ...
June 2026
170 pages
